The bio-based industry plays a strategic role in Europe’s transition to a sustainable and competitive economy. A recent European Investment Bank report underscores the sector’s strong potential, while highlighting key barriers to the scale-up of innovative technologies, including regulatory fragmentation and limited access to finance.
Systemic change and harmonised regulation, coupled with effective financial support instruments, are essential factors to unlock the sector’s innovation potential.
